drugset
drugset / Trial / NCT03184415

Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis

NCT03184415 ↗

Phase 3 Terminated 230 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedParallel-groupDouble-blindTreatment

Summary

THe purpose of this study is to evaludate the Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients with Gastritis

Timeline

Start
2017-07-03
Primary completion
2018-05-17
Completion
2018-05-17

Outcome

Outcome not reported

Stopped: “lack of efficacy”

Drugs

EvaluationDrugModalityDoseRoute
Subject DWC20155 Unknown — —
Subject DWC20156 Unknown — —

Indications

gastritis